Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-24 @ 3:04 PM
NCT ID:
NCT00636259
Eligibility Criteria:
Inclusion Criteria:
* Patients with adenocarcinoma of the prostate
* Subjects with locally advanced, and/or metastatic prostate cancer for whom surgical castration or other medical interventions are not considered appropriate or acceptable
Exclusion Criteria:
* Any known history of abnormal liver function tests
* Any severe concomitant condition that would make it undesirable, in the clinician's opinion, for the subject to participate in the trial.
* Known hypersensitivity to bicalutamide or any of the components found in bicalutamide
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT00636259
Study Brief:
Protocol Section:
NCT00636259